T
Thomas W. Wakefield
Researcher at University of Michigan
Publications - 407
Citations - 23278
Thomas W. Wakefield is an academic researcher from University of Michigan. The author has contributed to research in topics: Venous thrombosis & Thrombosis. The author has an hindex of 68, co-authored 395 publications receiving 20620 citations. Previous affiliations of Thomas W. Wakefield include Conrad Hotels & Scripps Research Institute.
Papers
More filters
Journal Article
Protamine-induced reductions of endothelial cell ATP.
TL;DR: The toxicity may reside in the positive charges on these molecules and mitochondrial damage may account for reductions in cellular ATP and systemic oxygen consumption.
Journal ArticleDOI
Diagnostic biomarkers in venous thromboembolic disease.
TL;DR: D-dimer and P-selectin remain the most clinically valuable biomarkers for diagnosis of VTE, although it is best as a rule-out test because of its generally low specificity.
Journal ArticleDOI
National trends in venous disease
Geoffrey D. Barnes,Sameer Gafoor,Thomas W. Wakefield,Gilbert R. Upchurch,Peter K. Henke,James B. Froehlich +5 more
TL;DR: Nationally, a significant and growing number of patients with venous disease are being seen in the outpatient setting by PCPs and specialists, but without a trend away from care in the ED over the 10-year study period.
Journal ArticleDOI
Age is not a barrier to good outcomes after varicose vein procedures.
Danielle C. Sutzko,Elizabeth Andraska,Andrea T. Obi,Mikel Sadek,Lowell S. Kabnick,Thomas W. Wakefield,Nicholas H. Osborne +6 more
TL;DR: Patients older than 65 years appear to benefit fromvaricose vein procedures and should not be denied interventions on their varicose veins and venous insufficiency on the basis of their age only.
Journal ArticleDOI
Clinical outcomes after varicose vein procedures in octogenarians within the Vascular Quality Initiative Varicose Vein Registry.
Danielle C. Sutzko,Andrea T. Obi,Andrew Kimball,Margaret E. Smith,Thomas W. Wakefield,Nicholas H. Osborne +5 more
TL;DR: V procedures in octogenarians have statistically significant improvement of Venous Clinical Severity Score and patient-reported outcomes with a low risk of complications despite more advanced venous disease at presentation.